Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight
Jersey City, New Jersey, April 24, 2026, 09:55 Organon & Co. shares rose sharply Friday after The Economic Times reported that India’s Sun Pharmaceutical Industries had submitted a binding, all-cash offer of about $13 billion for the U.S. women’s health drugmaker, stepping up a takeover race that also includes EQT and Germany’s Grünenthal. The newspaper said the offer was backed by $12 billion in financing from JPMorgan, MUFG and Citi, and that Organon shareholders would not receive Sun Pharma stock.
